Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ChiCTR2100052095
ChiCTR2100052095Not yet recruiting回顾性研究

骨骼肌含量与男性功能的关系

四川大学1 site in 1 country100 target enrollmentStarted: November 1, 2022Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Interventions

Trial Snapshot

Phase
回顾性研究
Status
Not yet recruiting
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
简明男性性功能量表
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

探索通过腿部骨骼肌含量与男性各方面功能的关系

Study Design

Study Type
观察性研究
Primary Purpose
单臂
Masking
N/a

Eligibility Criteria

Ages
18 to 65 (—)
Sex
Male

Inclusion Criteria

  • •在华西医院进行减肥手术的男性代谢综合征患者。

Exclusion Criteria

  • •本身有勃起功能障碍的患者；
  • •近 6 个月内服用抗抑郁等相关药物。

Arms & Interventions

1

No

Intervention: No

Outcomes

Primary Outcomes

简明男性性功能量表

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
四川大学

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Unknown
玛卡对于男性运动耐力研究运动损伤
ChiCTR200003980640
Unknown
Not Applicable
股神经阻滞对下肢运动功能抑制的性别差异的临床研究
ChiCTR1800014562浙江省医药卫生科技项目60
Recruiting
Phase 1
A study in healthy men to test how well different doses of BI 3776528 are tolerated
2024-515222-92-00Boehringer Ingelheim International GmbH118
Completed
Phase 1
A study in healthy men to test how well different doses of BI 3731579 are tolerated
2023-510318-25-00Boehringer Ingelheim International GmbH64
Recruiting
Phase 1
A study in healthy men to find out how different doses of BI 3009947 are tolerated and how different formulations or food influence how BI 3009947 is taken up into the blood
2025-521095-66-00Boehringer Ingelheim International GmbH68